Global Induced Pluripotent Stem Cells (iPSc) Market Research Report 2022 (Status and Outlook)

Global Induced Pluripotent Stem Cells (iPSc) Market Research Report 2022 (Status and Outlook)

Report Overview:

Induced pluripotent stem cells are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery.

The Global Induced Pluripotent Stem Cells (iPSc) Market Size was estimated at USD 101.38 million in 2021 and is projected to reach USD 228.36 million by 2028, exhibiting a CAGR of 12.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Induced Pluripotent Stem Cells (iPSc) Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.

Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Lonza

Axol Bioscience Ltd.

Evotec

Hitachi Ltd.

Merck KGaA

REPROCELL Inc.

Fate Therapeutics

Thermo Fisher Scientific, Inc.

StemCellFactory III

Applied StemCell Inc.

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon harma

Astellas Pharma Inc

Pluricell Biotech

Cell Inspire Biotechnology

Market Segmentation (by Type)

Hepatocytes

Fibroblasts

Keratinocytes

Amniotic Cells

Market Segmentation (by Application)

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the market

Overview of the regional outlook of the market:

Key Reasons to Buy this Report:

Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change

This enables you to anticipate market changes in order to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents

The concise analysis, clear graph and table format will enable you to pin point the information your require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSc)
1.2 Key Market Segments
1.2.1 Induced Pluripotent Stem Cells (iPSc) Segment by Type
1.2.2 Induced Pluripotent Stem Cells (iPSc) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Induced Pluripotent Stem Cells (iPSc) Market Overview
2.1 Global Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Induced Pluripotent Stem Cells (iPSc) Market Competitive Landscape
3.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2017-2022)
3.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2017-2022)
3.3 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites, Area Served, Product Type
3.6 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends
3.6.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
4.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Induced Pluripotent Stem Cells (iPSc) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)
6.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2017-2022)
6.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2017-2022)
7 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2017-2022)
7.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2017-2022)
7.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)
8 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Region
8.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region
8.2 North America
8.2.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Lonza
9.1.1 Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information
9.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
9.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Axol Bioscience Ltd.
9.2.1 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
9.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
9.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.2.4 Axol Bioscience Ltd. Business Overview
9.2.5 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
9.2.6 Axol Bioscience Ltd. Recent Developments
9.3 Evotec
9.3.1 Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information
9.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
9.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.3.4 Evotec Business Overview
9.3.5 Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
9.3.6 Evotec Recent Developments
9.4 Hitachi Ltd.
9.4.1 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
9.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
9.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.4.4 Hitachi Ltd. Business Overview
9.4.5 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
9.4.6 Hitachi Ltd. Recent Developments
9.5 Merck KGaA
9.5.1 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information
9.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
9.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.5.4 Merck KGaA Business Overview
9.5.5 Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
9.5.6 Merck KGaA Recent Developments
9.6 REPROCELL Inc.
9.6.1 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
9.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
9.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.6.4 REPROCELL Inc. Business Overview
9.6.5 REPROCELL Inc. Recent Developments
9.7 Fate Therapeutics
9.7.1 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information
9.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
9.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.7.4 Fate Therapeutics Business Overview
9.7.5 Fate Therapeutics Recent Developments
9.8 Thermo Fisher Scientific, Inc.
9.8.1 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
9.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
9.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.8.4 Thermo Fisher Scientific, Inc. Business Overview
9.8.5 Thermo Fisher Scientific, Inc. Recent Developments
9.9 StemCellFactory III
9.9.1 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information
9.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
9.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.9.4 StemCellFactory III Business Overview
9.9.5 StemCellFactory III Recent Developments
9.10 Applied StemCell Inc.
9.10.1 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
9.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
9.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.10.4 Applied StemCell Inc. Business Overview
9.10.5 Applied StemCell Inc. Recent Developments
9.11 Fujifilm Holding Corporation (CDI)
9.11.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information
9.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
9.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.11.4 Fujifilm Holding Corporation (CDI) Business Overview
9.11.5 Fujifilm Holding Corporation (CDI) Recent Developments
9.12 Ncardia
9.12.1 Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information
9.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
9.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.12.4 Ncardia Business Overview
9.12.5 Ncardia Recent Developments
9.13 Sumitomo Dainippon harma
9.13.1 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information
9.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
9.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.13.4 Sumitomo Dainippon harma Business Overview
9.13.5 Sumitomo Dainippon harma Recent Developments
9.14 Astellas Pharma Inc
9.14.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information
9.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
9.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.14.4 Astellas Pharma Inc Business Overview
9.14.5 Astellas Pharma Inc Recent Developments
9.15 Pluricell Biotech
9.15.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information
9.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
9.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.15.4 Pluricell Biotech Business Overview
9.15.5 Pluricell Biotech Recent Developments
9.16 Cell Inspire Biotechnology
9.16.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information
9.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
9.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance
9.16.4 Cell Inspire Biotechnology Business Overview
9.16.5 Cell Inspire Biotechnology Recent Developments
10 Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
10.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast
10.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
10.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region
10.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSc) by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)
11.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)
11.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2022-2028)
11.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application
11.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings